131 related articles for article (PubMed ID: 9221629)
1. [Dissent over standards in adjuvant management of colon carcinoma].
Lorenz M; Waldeyer M; Encke A
Zentralbl Chir; 1997; 122(4):210-21; discussion 222-3. PubMed ID: 9221629
[TBL] [Abstract][Full Text] [Related]
2. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
Gill S; Loprinzi CL; Sargent DJ; Thomé SD; Alberts SR; Haller DG; Benedetti J; Francini G; Shepherd LE; Francois Seitz J; Labianca R; Chen W; Cha SS; Heldebrant MP; Goldberg RM
J Clin Oncol; 2004 May; 22(10):1797-806. PubMed ID: 15067028
[TBL] [Abstract][Full Text] [Related]
3. [Adjuvant systemic chemo- or immunotherapy of colon cancer].
Schlag PM
Chirurg; 1994 Jun; 65(6):503-8. PubMed ID: 8088205
[TBL] [Abstract][Full Text] [Related]
4. [Adjuvant treatment of colonic carcinoma].
Rochlitz CF; Herrmann R
Praxis (Bern 1994); 1995 Nov; 84(47):1373-6. PubMed ID: 7501918
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant therapy for stage III colon cancer after complete resection. Provincial Gastrointestinal Disease Site Group.
Figueredo A; Fine S; Maroun J; Walker-Dilks C; Wong S
Cancer Prev Control; 1997 Oct; 1(4):304-19. PubMed ID: 9765754
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III.
Taal BG; Van Tinteren H; Zoetmulder FA;
Br J Cancer; 2001 Nov; 85(10):1437-43. PubMed ID: 11720425
[TBL] [Abstract][Full Text] [Related]
7. Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer.
Poplin EA; Benedetti JK; Estes NC; Haller DG; Mayer RJ; Goldberg RM; Weiss GR; Rivkin SE; Macdonald JS
J Clin Oncol; 2005 Mar; 23(9):1819-25. PubMed ID: 15774775
[TBL] [Abstract][Full Text] [Related]
8. New adjuvant therapy for colon cancer: justified hope or commercial hype.
Galanis E; Alberts SR; O'Connell MJ
Surg Oncol Clin N Am; 2000 Oct; 9(4):813-23; discussion 825-6. PubMed ID: 11008249
[TBL] [Abstract][Full Text] [Related]
9. [Current aspects of adjuvant and palliative chemotherapy in colorectal carcinoma].
Bokemeyer C; Hartmann JT; Kanz L
Praxis (Bern 1994); 1997 Sep; 86(39):1510-6. PubMed ID: 9411671
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant chemotherapy for colon cancer.
Ducreux M; Boige V
Best Pract Res Clin Gastroenterol; 2002 Apr; 16(2):283-98. PubMed ID: 11969239
[TBL] [Abstract][Full Text] [Related]
11. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
[TBL] [Abstract][Full Text] [Related]
12. [Results of chemotherapy in cancers of the colon].
Seitz JF; Rougier P
Bull Cancer; 1994 Apr; 81(4):260-76. PubMed ID: 7535602
[TBL] [Abstract][Full Text] [Related]
13. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.
Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM;
Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829
[TBL] [Abstract][Full Text] [Related]
14. Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089.
Haller DG; Catalano PJ; Macdonald JS; O'Rourke MA; Frontiera MS; Jackson DV; Mayer RJ
J Clin Oncol; 2005 Dec; 23(34):8671-8. PubMed ID: 16314627
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant therapy for stage II colon cancer after complete resection. Provincial Gastrointestinal Disease Site Group.
Figueredo A; Germond C; Maroun J; Browman G; Walker-Dilks C; Wong S
Cancer Prev Control; 1997 Dec; 1(5):379-92. PubMed ID: 9765760
[TBL] [Abstract][Full Text] [Related]
16. [Adjuvant chemotherapy in cancers of the colon and rectum].
Bleiberg H
Rev Prat; 1994 Dec; 44(20):2721-6. PubMed ID: 7878362
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant therapy for colon adenocarcinoma: current status of clinical investigation.
Köhne-Wömpner CH; Schöffski P; Schmoll HJ
Ann Oncol; 1994; 5 Suppl 3():97-104. PubMed ID: 8204538
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant sequential methotrexate --> 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer.
Sobrero A; Frassineti G; Falcone A; Dogliotti L; Rosso R; Di Costanzo F; Bruzzi P;
Br J Cancer; 2005 Jan; 92(1):24-9. PubMed ID: 15611795
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant therapy for colorectal carcinoma.
Kim R; Yamaguchi Y; Toge T
Anticancer Res; 2002; 22(4):2413-8. PubMed ID: 12174936
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant therapy with the monoclonal antibody Edrecolomab plus fluorouracil-based therapy does not improve overall survival of patients with stage III colon cancer.
Fields AL; Keller A; Schwartzberg L; Bernard S; Kardinal C; Cohen A; Schulz J; Eisenberg P; Forster J; Wissel P
J Clin Oncol; 2009 Apr; 27(12):1941-7. PubMed ID: 19273708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
